Pear Therapeutics, Inc. (“Pear Therapeutics”), the leader in developing and commercializing software-based medicines, called prescription digital therapeutics (PDTs) , announced today the completion...
Pear Therapeutics, Inc. , the leader in developing and commercializing software-based medicines called prescription digital therapeutics (PDTs), today announced management will participate in the Evercore...
Pear Therapeutics, Inc. , the leader in developing and commercializing software-based medicines called prescription digital therapeutics (PDTs), today announced that it has received Breakthrough Device...
Pear Therapeutics, Inc. (“Pear”), the leader in developing and commercializing software-based medicines, called prescription digital therapeutics (PDTs), today provides an update on significant progress...
Today, Thimble Point Acquisition Corp, Inc. (NASDAQ: THMA) (“Thimble Point”), a special purpose acquisition company, Pear Therapeutics, Inc. (“Pear”), the leader in developing and commercializing...
Pear Therapeutics, Inc. today announced the inclusion of Pear’s FDA-authorized prescription digital therapeutics (PDTs) reSET® and reSET-O® on the November 2021 MassHealth Drug List Summary Update...
Pear Therapeutics, Inc. , the leader in developing and commercializing prescription digital therapeutics (PDTs) to treat serious disease, today announced management’s participation in the virtual BTIG...
Pear Therapeutics, Inc. (“Pear”), the leader in developing and commercializing prescription digital therapeutics (“PDTs”) to treat serious disease , and Thimble Point Acquisition Corp. (“Thimble...
Pear Therapeutics, Inc. (“Pear”), the leader in developing and commercializing prescription digital therapeutics (“PDTs”) to treat serious disease, and Thimble Point Acquisition Corp. (Nasdaq:...
NEW YORK, July 10, 2021 (GLOBE NEWSWIRE) --
WILMINGTON, Del., June 29, 2021 (GLOBE NEWSWIRE) -- Rigrodsky Law, P.A. announces that it is investigating Thimble Point Acquisition Corp. (“Thimble Point”) (NASDAQ GS: THMA ) regarding possible...
NEW YORK, June 28, 2021 (GLOBE NEWSWIRE) --
NEW YORK, June 24, 2021 (GLOBE NEWSWIRE) -- Moore Kuehn, PLLC, a law firm focusing in securities litigation located on Wall Street in downtown New York City, is investigating potential claims concerning...
Pear Therapeutics, Inc. (“Pear”), the leader in developing and commercializing prescription digital therapeutics (PDTs) to treat serious disease, and Thimble Point Acquisition Corp. (“Thimble Point”)...